ANTIESTROGENS IN TREATMENT OF BREAST-CANCER

被引：90

作者：

LEGHA, SS

CARTER, SK

机构：

[1] NCI, DIV CANC TREATMENT, INVEST DRUG BRANCH, PROGRAM CANC THERAPY EVAL, BETHESDA, MD 20014 USA

[2] NO CALIF CANC PROGRAM, PALO ALTO, CA 94304 USA

来源：

CANCER TREATMENT REVIEWS | 1976年 / 3卷 / 04期

关键词：

D O I：

10.1016/S0305-7372(76)80010-2

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：205 / 216

页数：12

共 63 条

[21]

HARPER MJK, 1967, J REPROD FERTIL, V13, P101

[22] CONTRASTING ENDOCRINE ACTIVITIES OF CIS AND TRANS ISOMERS IN A SERIES OF SUBSTITUTED TRIPHENYLETHYLENES [J].

HARPER, MJK ;

WALPOLE, AL .

NATURE, 1966, 212 (5057) :87-&

[23] CLINICAL TRIAL OF CLOMIPHENE IN ADVANCED BREAST-CANCER [J].

HECKER, E ;

VEGH, I ;

LEVY, CM ;

MAGIN, CA ;

MARTINEZ, JC ;

LOUREIRO, J ;

GAROLA, RE .

EUROPEAN JOURNAL OF CANCER, 1974, 10 (11) :747-749

[24]

HERBST AL, 1964, CANCER CHEMOTH REP, P39

[25]

HEUSON J C, 1972, European Journal of Cancer, V8, P387

[26] COMPARATIVE TRIAL OF NAFOXIDINE AND ETHINYLESTRADIOL IN ADVANCED BREAST-CANCER - EORTC STUDY [J].

HEUSON, JC ;

ENGELSMAN, E ;

BLONKVANDERWIJST, J ;

MAASS, H ;

DROCHMANS, A ;

MICHEL, J ;

NOWAKOWSKI, H ;

GORINS, A .

BRITISH MEDICAL JOURNAL, 1975, 2 (5973) :711-713

[27]

JENSEN EV, 1971, 34 NAT CANC I MON, P55

[28] INHIBITION OF ESTROGEN-STIMULATED PROLACTIN-RELEASE BY ANTI-OESTROGENS [J].

JORDAN, VC ;

KOERNER, S ;

ROBISON, C .

JOURNAL OF ENDOCRINOLOGY, 1975, 65 (01) :151-152

[29]

JORDAN VC, 1975, J REPROD FERTIL, V42, P251

[30] ANTITUMOR ACTIVITY OF ANTIESTROGEN ICI 46,474 (TAMOXIFEN) IN DIMETHYLBENZANTHRACENE (DMBA)-INDUCED RAT MAMMARY-CARCINOMA MODEL [J].

JORDAN, VC .

JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1974, 5 (04) :354-354

← 1 2 3 4 5 6 7 →